| pubmed-article:2782975 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2782975 | lifeskim:mentions | umls-concept:C0032533 | lld:lifeskim |
| pubmed-article:2782975 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:2782975 | lifeskim:mentions | umls-concept:C0038317 | lld:lifeskim |
| pubmed-article:2782975 | lifeskim:mentions | umls-concept:C0039483 | lld:lifeskim |
| pubmed-article:2782975 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:2782975 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:2782975 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:2782975 | pubmed:dateCreated | 1989-10-20 | lld:pubmed |
| pubmed-article:2782975 | pubmed:abstractText | Thirty nine patients with polymyalgia rheumatica (PMR) and 35 with giant cell arteritis (GCA) were treated with high or low dose steroid regimens in a prospective study of the first two months of treatment. Patients with PMR needed 15-20 mg prednisolone initially; 13/20 (65%) relapsed on an initial dose of 10 mg/day. All but two patients with GCA were successfully treated with 40 mg/day prednisolone initially but relapsed on a reduction to 20 mg/day. One patient with GCA receiving 30 mg/day relapsed after four weeks. Six patients with PMR developed GCA during the first two months and required an increased prednisolone dose to control symptoms. The erythrocyte sedimentation rate or C reactive protein did not predict relapse. | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2782975 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2782975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2782975 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2782975 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:2782975 | pubmed:issn | 0003-4967 | lld:pubmed |
| pubmed-article:2782975 | pubmed:author | pubmed-author:HazlemanB LBL | lld:pubmed |
| pubmed-article:2782975 | pubmed:author | pubmed-author:KyleVV | lld:pubmed |
| pubmed-article:2782975 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2782975 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:2782975 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2782975 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2782975 | pubmed:pagination | 658-61 | lld:pubmed |
| pubmed-article:2782975 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:meshHeading | pubmed-meshheading:2782975-... | lld:pubmed |
| pubmed-article:2782975 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2782975 | pubmed:articleTitle | Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. | lld:pubmed |
| pubmed-article:2782975 | pubmed:affiliation | Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge. | lld:pubmed |
| pubmed-article:2782975 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2782975 | lld:pubmed |
